Bayesian Adaptive Design for Immunotherapy and Targeted Therapy
Published on 21. April 2024
Book
Paperback/Softback
XI, 262 pages
978-981-19-8467-9 (ISBN)
Description
This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-escalation study, proof-of-concept trials, and confirmatory studies with registrational. The book includes real-life examples and software to facilitate practitioners to learn and use the designs in practice.
More details
Edition
2023 ed.
Language
English
Place of publication
Singapore
Singapore
Target group
Professional and scholarly
Illustrations
8 s/w Abbildungen, 50 farbige Abbildungen
XI, 262 p. 58 illus., 50 illus. in color.
Dimensions
Height: 235 mm
Width: 155 mm
Thickness: 16 mm
Weight
423 gr
ISBN-13
978-981-19-8467-9 (9789811984679)
DOI
10.1007/978-981-19-8176-0
Schweitzer Classification
Other editions
Additional editions
Haitao Pan | Ying Yuan
Bayesian Adaptive Design for Immunotherapy and Targeted Therapy
Book
04/2023
Springer
€160.49
Shipment within 3-4 weeks
Content
Introduction to Adaptive Design and Delayed Outcomes.- Basics of Bayesian Statistics.- Phase I Dose-finding Design.- Phase II Design for Interim Monitoring.- Phase I-II Dose-finding Design.- Drug Combination Trial Design.- Conclusion.